Bristol Myers discloses $39 million in Russia exit costs

1 min read
Test tubes are seen in front of a displayed Bristol Myers Squibb logo in this illustration

(Reuters) – Bristol Myers Squibb Co said on Wednesday it had transferred its commercial operations in Russia to a third-party distributor and incurred $39 million in related costs.

The drugmaker said in a filing that its remaining assets in the country were not material. (

(Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila)